Journal Guide

The Journal of Laboratory Medicine (JLM) is a bi-monthly published journal that reports on the latest developments in laboratory medicine. Particular focus is placed on the diagnostic aspects of the clinical laboratory, although technical, regulatory, and educational topics are equally covered. . The journal specializes in the publication of high-standard review articles on clinical, methodological and pathogenic aspects of modern laboratory diagnostics. These reviews are critically reviewed by JLM’s associate editors who are specialists in the various subdisciplines of laboratory medicine. In addition, JLM continues to publish original research articles, case reports and letters to the editor, all of which are peer reviewed by at least two experts in the field.

Better job prospects. Higher salaries. The respect of your colleagues. The confidence that comes from knowing you’re fully qualified to be a top-notch laboratory professional. Since 1928, certification by the ASCP Board of Certification (BOC) (formerly the ASCP Board of Registry) has been the industry standard for laboratory professionals.

Lipids in Health and Disease is ready to receive manuscripts on all aspects of lipids in health and disease.

Machine Learning: Health is a multidisciplinary open access journal dedicated to the application of machine learning, artificial intelligence (AI) and data-driven computational methods across healthcare and the medical, biological, clinical, and health sciences. The journal also publishes research that presents methodological, theoretical, or conceptual advances in machine learning and AI with applications to medicine and health sciences.

Materials Chemistry Frontiers is devoted to the publication of original contributions at the interface of chemistry and materials science, with topics spanning but not limited to energy materials, catalysis, biomaterials, nanoscience, polymers, luminescent materials, and sensors. The journal places an emphasis on original research that demonstrates conceptual advancements with emerging applications, rather than primarily reporting technological improvements. Together with Organic Chemistry Frontiers and Inorganic Chemistry Frontiers, this suite of journals offers an authoritative portfolio that is jointly owned by the Chinese Chemical Society, the Royal Society of Chemistry, and partner institutions.

Molecular Cytogenetics encompasses all aspects of chromosome biology and the application of molecular cytogenetic techniques in all areas of biomedicine.

Molecular Omics publishes high-quality research from across the -omics sciences that provide significant new insight into important chemical or biological problems. Topics covered by Molecular Omics include, but are not limited to, proteomics, genomics, transcriptomics, lipidomics, glycomics, metabolomics, microbiomics, sequencing technologies and bioinformatic research. Molecular Omics articles report research that significantly increases understanding or demonstrates clear functional benefits, supported by experimental validation or a novel data analytic approach. Topics include, but are not limited to: -omics studies to gain mechanistic insight into biological processes; -omics studies for clinical applications with experimental validation, such as finding biomarkers for diagnostics or potential new drug targets; -omics studies looking at the sub-cellular make-up of cells – for example, the subcellular localisation of certain proteins or post-translational modifications or new imaging techniques; studies presenting new methods and tools to support omics studies, including new spectroscopic/chromatographic techniques, chip-based/array technologies and new classification/data analysis techniques.

Organic Chemistry Frontiers is an international forum for cutting-edge research from all disciplines of organic chemistry, with topics spanning but not limited to organic synthesis, catalysis, natural products, functional organic materials, supramolecular and macromolecular chemistry, physical and computational chemistry, medicinal chemistry, and bioorganic chemistry. Emphases are placed on studies that make significant contributions to the field of organic chemistry by reporting either new or significantly improved protocols or methodologies. Together with Inorganic Chemistry Frontiers and Materials Chemistry Frontiers, this suite of journals offers an authoritative portfolio that is jointly owned by the Chinese Chemical Society, the Royal Society of Chemistry, and partner institutions.

Pulmonary Pharmacology and Therapeutics (formerly Pulmonary Pharmacology) is concerned with lung pharmacology from molecular to clinical aspects. The subject matter encompasses the major diseases of the lung including asthma, cystic fibrosis, pulmonary circulation, ARDS, carcinoma, bronchitis, emphysema and drug delivery. Laboratory and clinical research on man and animals will be considered including studies related to chemotherapy of cancer, tuberculosis and infection. In addition to original research papers the journal will include review articles and book reviews.Research Areas Include:• All major diseases of the lung• Physiology• Pathology• Drug delivery• Metabolism• Pulmonary ToxicologyBefore submitting, please note the "Rules of 5" defining immediate rejection criteria of PPT:1. Out of scope: The paper should report on the use of pharmacological or toxicological studies (positive or negative) that are directly related to Pulmonary Pharmacology & Therapeutics.Immediate rejection criteria are: a) Testing of extracts or plant parts that are not characterized b) Case Reports or n=1 studies2. Too preliminary: A paper must be based on a thorough and extensive study, using proper controlsImmediate rejection criteria are: a) In vitro studies with a single dose, or very high concentration b) Single dose studies with very few animals, no dose-response studies c) No proper controls. d) Repetition or confirmation of an earlier work3. Unethical: The study must have been carried under appropriate ethical approval for the study (either animal or human).4. Inappropriate experiments or lacking essential detailImmediate rejection criteria are: a) Wrong species or lacking details on the exact number of animals/subjects used b) No details of structure if a new drug is used for the first time5. Lack of novelty: The study must represent a novel approach to the field.Immediate rejection criteria are: a) Repetition of well known data b) No advance of knowledge in the fieldNote that only manuscripts written in good English will be considered by the Editors (British usage is preferred).

At the heart of open access for the global chemistry community. RSC Advances publishes advances in chemistry, and in topics of interest to the chemistry community.

RSC Chemical Biology is a gold open access journal dedicated to publishing and disseminating exceptional, breakthrough research and high-quality reviews at the interface of chemistry and biology. We welcome contributions from across the breadth of the chemical biology field. This includes Sensing and Imaging, Bioorthogonal chemistry, Biosynthesis, Biomimetics and Bioengineering, Synthetic biology, Directed evolution, Drugs development and mechanism of action, Glycoscience, Natural products, Nucleic acids, Peptides, Phenotypic screening, Proteins (including protein-protein interactions, modifications, structure and function) We are particularly interested in reports on the application of chemical tools to probe, explore and visualize biological systems and processes to provide insights into molecular mechanisms in health and disease. We also encourage translational research that bridges chemistry and chemical biology to medicine.

RSC Medicinal Chemistry publishes significant research in medicinal chemistry and related drug discovery science. Research articles published in RSC Medicinal Chemistry must show a breakthrough or significant advance on previously published work, or bring new thinking or results that will have a strong impact in their field. Topics within the journal's scope include, but are not limited to: design, synthesis and biological evaluation of novel chemical entities or biotherapeutic modalities; modifications of known chemical entities or biotherapeutic modalities that result in a significantly greater understanding of their structure-activity relationships, an improvement of their properties or provide other information of significant value; novel methodologies and technologies in the broader chemical and biological sciences; computational, machine learning and artificial intelligence (AI) studies are welcome where they significantly advance medicinal chemistry knowledge; studies that examine the effect of the molecular structure of a compound on pharmacokinetic behaviour and pharmacodynamics; studies that present new insights into drug design based on analysis of existing experimental datasets or new theoretical approaches if supported by experimental evidence; studies presenting new drug delivery systems with novel chemical agents are welcomed, in particular those that involve chemical modification of the delivery system of conjugation with novel delivery vectors.

Maney delivers personalised service to authors, societies, readers and libraries for the publishing and international dissemination of high quality, peer-reviewed scholarship and research. Specialising in print and electronic journal publishing, Maney is committed to technical and editorial innovation combined with traditional values of quality and collaboration.Maney Publishing is an independent publishing company specialising in academic journals in materials science and engineering, the humanities, and health science. Maney is committed to publishing high quality journals in print and electronic formats that are international in scope and peer-reviewed. With offices in Leeds and London in the UK, and in Boston and Philadelphia in North America, Maney publishes extensively for learned societies, universities and professional bodies around the world.

Chaque mois, la Revue francophone des laboratoires propose a ses lecteurs:toute l'actualité scientifique professionnelle à travers une revue de presse internationale et des échos rédigés par les membres de notre comité scientifique,un dossier scientifique consacré à un thème de fond en biologie médicale, composé d'articles scientifiques de très haut niveau couvrant les différents phénomènes biologiques et les différentes techniques d'analyses,Un dossier du technicien plus "pratique" spécialement destiné à la formation des techniciens de laboratoires,des rubriques régulières comme Cas clinique et Fiche technique illustrant, à partir d'un cas concret, une méthode de diagnostic ou une technique d'analyse,une veille juridique, complément indispensable pour la bonne exécution des analyses.

Aims and Scope Download Flyer The Chemical Record (TCR) is a “highlights” journal publishing timely and critical overviews of new developments at the cutting edge of chemistry of interest to a wide audience of chemists (2009 journal impact factor: 3.862). The scope of published reviews includes all areas related to physical chemistry. analytical chemistry. inorganic chemistry. organic chemistry. polymer chemistry. materials chemistry. bioorganic chemistry. biochemistry. biotechnology and medicinal chemistry as well as interdisciplinary fields. TCR provides carefully selected highlight papers by leading researchers that introduce the author’s own experimental and theoretical results in a framework designed to establish perspectives with earlier and contemporary work and provide a critical review of the present state of the subject. The articles are intended to present concise evaluations of current trends in chemistry research to help chemists gain useful insights into fields outside their specialization and provide experts with summaries of recent key developments. Authors are encouraged to give perspectives on their own personal thinking and the historical development that led to significant breakthroughs in research.New developments from industrial laboratories will be featured in a separate section covering corporate research. All manuscripts are peer-reviewed. Manuscripts are generally solicited by the editors. however. voluntary contributions are also welcome. In the latter case potential authors are asked to contact the Editorial Office with an outline before beginning to write in order to avoid duplication of effort and to ensure suitability of the topic and the level of coverage.

The Journal of Clinical Endocrinology & Metabolism is the world's leading peer-reviewed journal for endocrine clinical research and cutting edge clinical practice reviews. Each issue provides the latest in-depth coverage of new developments enhancing our understanding, diagnosis and treatment of endocrine and metabolic disorders. Regular features of special interest to endocrine consultants include clinical trials, clinical reviews, clinical practice guidelines, case seminars, and controversies in clinical endocrinology, as well as original reports of the most important advances in patient-oriented endocrine and metabolic research. According to the latest Thomson Reuters Journal Citation Report, JCE&M articles were cited 65,847 times in 2009. Also in 2009, it has an Impact Factor of 6.202 and is ranked 10th out of 105 journals in the category of Endocrinology and Metabolism.

Transfusion Clinique et Biologique publishes original papers, general reviews, clinical cases, letters to the editor and editorials concerning transfusion activity in all its scientific and medical aspects.
Articles in English are also accepted.
In the CME section, update articles are published, together with self-evaluations and litterature reviews.

Benefits to authors
We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our http://www.elsevier.com/wps/find/authorsview.authors/authorservicesauthor services.

Please see our http://www.elsevier.com/wps/find/journaldescription.cws_home/623385/authorinstructionsGuide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com